Cherry Creek Investment Advisors, Inc. Repligen Corp Transaction History
Cherry Creek Investment Advisors, Inc.
- $187 Million
- Q1 2025
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 2,752 shares of RGEN stock, worth $362,383. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,752
Previous 2,752
-0.0%
Holding current value
$362,383
Previous $396,000
11.62%
% of portfolio
0.19%
Previous 0.2%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$997 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$996 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$669 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$222 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$220 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.31B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....